Insider Transactions Reported by 25 Insiders of Roivant Sciences Ltd.

Symbol
ROIV on Nasdaq
Location
London

Insiders trading volume in the past year

Roivant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $1,064,491,735 10 Nov 2022
Vivek Ramaswamy 10%+ Owner $1,012,161,165 -$160,007,087 -14% 11 Dec 2025
SVF Investments (UK) Ltd 10%+ Owner $755,877,753 28 Sep 2023
Sumitomo Chemical Co., Ltd. 10%+ Owner $737,448,709 22 Jun 2023
Mayukh Sukhatme President & CIO, Director $498,603,399 -$38,507,032 -7.2% 09 Feb 2026
Keith S. Manchester Director $400,874,218 -$98,028,232 -20% 11 Feb 2026
QVT Financial LP Director by Deputization $400,874,218 -$98,028,232 -20% 11 Feb 2026
Daniel Allen Gold Director $400,874,218 -$98,028,232 -20% 11 Feb 2026
Frank Torti President and Vant Chair $377,892,407 -$82,039,460 -18% 19 Feb 2026
Matthew Gline CEO, Director $374,783,916 -$37,673,243 -9.1% 15 Dec 2025
Eric Venker President & Immunovant CEO $167,598,168 -$101,828,846 -38% 20 Feb 2026
VIKING GLOBAL INVESTORS LP 10%+ Owner $133,352,577 22 Jun 2023
VIKING GLOBAL PERFORMANCE LLC 10%+ Owner $133,352,577 22 Jun 2023
Benjamin Zimmer President, Roivant Health $12,083,532 01 Oct 2021
Richard Pulik Cfo $6,472,912 -$9,122,307 -58% 20 Feb 2026
Ilan Oren Director $2,744,455 20 Jan 2026
James C. Momtazee Director $2,505,509 20 Jan 2026
Rakhi Kumar Chief Accounting Officer $1,739,920 20 Feb 2025
Melissa B. Epperly Director $1,325,141 20 Jan 2026
Jennifer Humes Chief Accounting Officer $1,231,437 20 Mar 2025
Meghan FitzGerald Director $591,600 10 Sep 2025
Andrew Lo Director $539,670 15 Sep 2022
Patrick Machado Director 01 Oct 2021
Masayo Tada Director 01 Oct 2021
Hiroshi Nomura Director 16 Sep 2022

Recent Insider Transactions by Companies or Individuals for Roivant Sciences Ltd.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Frank Torti ROIV Common Shares Sale -4.1% $16,159,099 $27.51 -587,390 13,736,547 23 Feb 2026 Direct
Frank Torti ROIV Common Shares Options Exercise 4.28% 587,390 14,323,937 23 Feb 2026 Direct
Frank Torti ROIV Stock Option (Right to Buy) Options Exercise -16.3% -587,390 3,026,184 23 Feb 2026 Direct
Richard Pulik ROIV Common Shares Tax liability -0.42% -1,000 238,413 20 Feb 2026 Direct
Eric Venker ROIV Common Shares Tax liability -0.43% -7,051 1,647,546 20 Feb 2026 Direct
Frank Torti ROIV Common Shares Sale -6.87% $27,492,362 $27.15 -1,012,610 13,736,547 20 Feb 2026 Direct
Frank Torti ROIV Common Shares Options Exercise 7.37% 1,012,610 14,749,157 20 Feb 2026 Direct
Frank Torti ROIV Stock Option (Right to Buy) Options Exercise -21.9% -1,012,610 3,613,574 20 Feb 2026 Direct
Frank Torti ROIV Common Shares Sale -9.25% $38,388,000 $27.42 -1,400,000 13,736,547 19 Feb 2026 Direct
Frank Torti ROIV Common Shares Options Exercise 10.2% 1,400,000 15,136,547 19 Feb 2026 Direct
Frank Torti ROIV Stock Option (Right to Buy) Options Exercise -23.2% -1,400,000 4,626,184 19 Feb 2026 Direct
Eric Venker ROIV Common Shares Sale -10.8% $5,298,000 $26.49 -200,000 1,654,597 13 Feb 2026 Direct
Eric Venker ROIV Common Shares Options Exercise 12.1% 200,000 1,854,597 13 Feb 2026 Direct
Eric Venker ROIV Stock Option (Right to Buy) Options Exercise -3.81% -200,000 5,044,834 13 Feb 2026 Direct
Keith S. Manchester ROIV Common Shares Sale -2.42% $9,956,768 $26.50 -375,784 15,127,329 13 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Daniel Allen Gold ROIV Common Shares Sale -2.42% $9,956,768 $26.50 -375,784 15,127,329 13 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
QVT Financial LP ROIV Common Shares Sale -2.42% $9,956,768 $26.50 -375,784 15,127,329 13 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Keith S. Manchester ROIV Common Shares Sale -2.67% $11,367,000 $26.75 -425,000 15,503,113 12 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Daniel Allen Gold ROIV Common Shares Sale -2.67% $11,367,000 $26.75 -425,000 15,503,113 12 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
QVT Financial LP ROIV Common Shares Sale -2.67% $11,367,000 $26.75 -425,000 15,503,113 12 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Keith S. Manchester ROIV Common Shares Sale -2.6% $11,334,750 $26.67 -425,000 15,928,113 11 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Daniel Allen Gold ROIV Common Shares Sale -2.6% $11,334,750 $26.67 -425,000 15,928,113 11 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
QVT Financial LP ROIV Common Shares Sale -2.6% $11,334,750 $26.67 -425,000 15,928,113 11 Feb 2026 Held by QVT Financial Investment Cayman Ltd.
Mayukh Sukhatme ROIV Common Shares Other -1.63% -312,117 18,836,547 09 Feb 2026 Direct
Mayukh Sukhatme ROIV Common Shares Sale -1.74% $8,985,003 $26.47 -339,441 19,148,664 09 Feb 2026 Direct
Mayukh Sukhatme ROIV Common Shares Options Exercise 3.46% 651,558 19,488,105 09 Feb 2026 Direct
Mayukh Sukhatme ROIV Stock Option (Right to Buy) Options Exercise -100% -651,558 0 09 Feb 2026 Direct
James C. Momtazee ROIV Common Shares Tax liability -0.11% -122 109,030 20 Jan 2026 Direct
James C. Momtazee ROIV Common Shares Award 0.56% 609 109,152 20 Jan 2026 Direct
Ilan Oren ROIV Common Shares Tax liability -0.1% -124 119,428 20 Jan 2026 Direct
Ilan Oren ROIV Common Shares Award 0.98% 1,164 119,552 20 Jan 2026 Direct
Melissa B. Epperly ROIV Common Shares Tax liability -0.09% -54 57,665 20 Jan 2026 Direct
Melissa B. Epperly ROIV Common Shares Award 1.43% 815 57,719 20 Jan 2026 Direct
Eric Venker ROIV Common Shares Sale -10.8% $4,384,000 $21.92 -200,000 1,654,597 12 Jan 2026 Direct
Eric Venker ROIV Common Shares Options Exercise 12.1% 200,000 1,854,597 12 Jan 2026 Direct
Eric Venker ROIV Stock Option (Right to Buy) Options Exercise -3.67% -200,000 5,244,834 12 Jan 2026 Direct
Mayukh Sukhatme ROIV Common Shares Other -7.06% -1,430,882 18,836,547 31 Dec 2025 Direct
Mayukh Sukhatme ROIV Common Shares Sale -4.79% $22,122,381 $21.71 -1,018,995 20,267,429 31 Dec 2025 Direct
Mayukh Sukhatme ROIV Common Shares Options Exercise 13% 2,449,877 21,286,424 31 Dec 2025 Direct
Mayukh Sukhatme ROIV Stock Option (Right to Buy) Options Exercise -96.2% -2,449,877 95,718 31 Dec 2025 Direct
Mayukh Sukhatme ROIV Common Shares Other -2.26% -436,485 18,836,547 29 Dec 2025 Direct
Mayukh Sukhatme ROIV Common Shares Sale -1.59% $6,780,119 $21.74 -311,873 19,273,032 29 Dec 2025 Direct
Mayukh Sukhatme ROIV Common Shares Options Exercise 3.97% 748,358 19,584,905 29 Dec 2025 Direct
Mayukh Sukhatme ROIV Stock Option (Right to Buy) Options Exercise -57.4% -748,358 555,840 29 Dec 2025 Direct
Frank Torti ROIV Common Shares Gift -0.8% -110,489 13,736,547 24 Dec 2025 Direct
Frank Torti ROIV Common Shares Other -0.47% -64,891 13,847,036 24 Dec 2025 Direct
Eric Venker ROIV Common Shares Sale -4.34% $1,689,750 $22.53 -75,000 1,654,597 24 Dec 2025 Direct
Eric Venker ROIV Common Shares Options Exercise 7.31% 117,848 1,729,597 24 Dec 2025 Direct
Eric Venker ROIV Stock Option (Right to Buy) Options Exercise -2.12% -117,848 5,444,834 24 Dec 2025 Direct
Frank Torti ROIV Common Shares Award 1.28% 175,380 13,911,927 23 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.